Principal Scientist
Genentech
South San Francisco
Dr. Rachel Shi is currently a Principal Scientist in the Department of Biochemical and Cellular Pharmacology at Genentech Research & Early Development. Rachel received her undergraduate degree from Tianjin University in China with a major in Pharmaceutical Science in 2011. Rachel then obtained her Ph.D. in Analytical Chemistry with Prof. David Clemmer at Indiana University Bloomington and performed her postdoctoral research with Prof. Michael Gross at Washington University in St. Louis. Before joining Genentech in the summer of 2021, Rachel worked at Amgen and AbbVie where she provided analytical support for CQA assessment, extensive characterization, and comparability studies of therapeutic proteins. Rachel’s studies at Genentech focus on developing and applying mass spectrometry-based assays for bioanalytical and biotransformation studies in the large molecule drug portfolio.
Disclosure information not submitted.
Bioanalysis of Emerging Modality Therapeutics Using Novel Mass Spectrometry Approaches
Wednesday, November 12, 2025
9:00 AM - 9:30 AM CT